Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ConCorD-19: Peginterferon beta-1a for SARS-CoV-2 Transmission Reduction
NCT04552379Phase 3Completed
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Dec 2020
- Primary completion
- May 2021
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon beta-1a in coronavirus disease 2019 (COVID-19), sponsored by Pontificia Universidad Católica de Chile. Started Dec 2020; status: completed.
02
Drugs
peginterferon beta-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04552379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04552379.